CYP19A1 and breast cancer: Some studies have examined CYP19A1 gene expression in breast cancer using quantitative reverse transcription polymerase chain reaction (RT-PCR), which is considered a standard method for the quantitative measurement of gene expression; however, many of these studies have shown controversial results [16, 17].